Perbedaan Fortune Mate Indonesia Tbk dan UBC Medical Indonesia Tbk.: Fortune Mate Indonesia Tbk diperdagangkan di Rp252 (kapitalisasi pasar 1,59 T, volume 24 jam 4,7 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: Fortune Mate Indonesia Tbk jauh lebih besar — sekitar 2,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 4,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| FMII | LABS | |
|---|---|---|
Kapitalisasi Pasar | 1,59 T | 635,95 M |
Volume | 4,7 rb | 843 rb |
Lot | 47 | 8,43 rb |
Perputaran | 1,17 jt | 137,6 jt |
Harga Rata-rata | 248,43 | 163,22 |
Nilai Transaksi | 1,17 jt | 137,6 jt |
Harga Ekuilibrium Indikatif | 248 | 165 |
Volume Ekuilibrium Indikatif | 200 | 246 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Selengkapnya di halaman FMII →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →